Wrap Text
Warrant Repricing, CLN Conversion & Investor Loan Reprofiling
Kibo Energy PLC (Incorporated in Ireland)
(Registration Number: 451931)
(External registration number: 2011/007371/10)
LEI code: 635400WTCRIZB6TVGZ23
Share code on the JSE Limited: KBO
Share code on the AIM: KIBO
ISIN: IE00B97C0C31
(‘Kibo’ or ‘the Company’)
Dated: 7am 11 April 2023
Kibo Energy PLC ('Kibo' or the 'Company')
Warrant Repricing, Convertible Loan Note Conversion and Reprofiling of Investor Loan
Kibo Energy PLC (AIM: KIBO; AltX: KBO), the renewable energy-focused development company,
announces that following extensive stakeholder engagement the Company has decided and agreed
upon several measures to ensure the Company’s financial and operational stability and to secure the
continuation of the Company’s development plans as outlined in its operational update RNS dated 6
April 2023.
These measures comprise the following three elements designed to ensure the Company has further
capital injections, to reduce its immediate liabilities to improve the balance sheet and to incentivise
the Company’s investors for longer-term returns:
* Warrant Repricing – the repricing of all the Company’s 1,128,024,625 unexercised
warrants currently in issue and linked with new incentive warrants, to be issued to warrant
holders on exercising their current Kibo warrants.
* Convertible Loan Notes Conversion – the conversion of the Company’s 7% Convertible
Loan Note Instrument issued on 7 January 2022, which has a current value (including
interest) of £714,517, to new ordinary Kibo shares of €0.001 par value each at a price of 0.14
pence per share.
* Bridge Loan Re-Profiling to amend it to a 24-month term loan – the reprofiling of the
Company’s existing bridge loan facility as announced in an RNS dated 16 February 2022,
with a current balance of £1,182,254 and currently due for payment on 28 April 2023.
As previously announced (RNSs dated 1 February 2023 and 6 April 2023), a key component of the
Company’s strategy is the proposed spin-out of a new company, Ultimate Sustainable Energy
(‘USE’), to be listed on the AIM Market (‘AIM’) of the London Stock Exchange (‘LSE’) via an
initial public offering (‘IPO’). It is envisioned that USE will contain the Company’s existing waste-
to-energy (‘WtE’) and biofuel project portfolio and the Company will provide the updated timing
for the proposed IPO in the general update referenced above.
The Board expects that the measures summarised above, and outlined in detail below, will, assist
with the funding required for the spin-out while incentivising existing long-term shareholders,
warrant holders and other stakeholders in having their interests aligned with the Company’s business
development goals across its entire project portfolio that spans reserve power, waste to energy,
biofuel and long duration energy storage (‘LDES’). (For an overview of the Kibo strategy and
project portfolio, the latest Company Corporate Presentation can be accessed on the Company
website at www.kibo.energy).
The agreement of current and former directors and management of the Company to convert Loan
Notes of £714,517 owed under the 7% Convertible Loan Note Instrument, not only demonstrates
their personal support of Kibo’s project portfolio and business strategy but also significantly
contributes towards deleveraging the Company’s balance sheet. Similarly, the agreement of the
Institutional Investor to reprofile its bridge loan facility further supports the development of the
Company’s operations and execution of its business strategy, while allowing the Company to
preserve much-needed capital for the further development of the Company’s existing project
portfolio. Further details on the measures being announced today are outlined below.
A. Warrant Repricing
All unexercised and outstanding warrants in the Company to the amount of 1,128,024,625 will be
repriced (the ‘Repriced Warrants’) such that they will all be exercisable at £0.001 (0.1p.) The
summary details of outstanding Kibo warrants are shown in Table 1 below.
Warrant
Number of Warrants Current Exercise New Exercise Price
Instrument Expiry Date
outstanding and unexpired Price (Repriced)
Reference
W.I 3 313,750,000 22 Sept 2023 0.4p 0.1p
W.I 5 216,000,000 22 Sept 2023 0.25p 0.1p
W.I 6 430,000,000 7 Nov 2023 0.4p 0.1p
W.I.7 168,274,625* 16 Feb 2025 0.231764p 0.1p
TOTAL 1,128,024,625
*All warrants held by institutional investor – see ‘C. Institutional Investor Loan’ below
Table 1: Summary of outstanding Kibo warrants
Each Repriced Warrant will permit the holders (the ‘Warrant Holders’) to subscribe for one ordinary
Kibo share of €0.001 par value at the new exercise price of 0.1p on or before the expiry dates, which
will remain unchanged.
The Company will also issue incentive warrants (the ‘Incentive Warrants’) to all Warrant Holders
who exercise their current warrants by 30 June 2023 following the repricing as well as to those
Warrant Holders who have already exercised warrants under the Warrant Instruments mentioned
above. One Incentive Warrant will be issued for each current warrant exercised, at an exercise price
of 0.25p with the following terms:
* Each Incentive Warrant will be exercisable for an 18-month period, commencing on
the date it is granted.
* Rights to exercise the Incentive Warrants will vest six (6) months from the grant date.
* Granting of Incentive Warrants will be conditional on the Company obtaining
necessary authorisations at a General Meeting.
* Incentive Warrants may only be exercised by warrant holders pro-rata to the number of
Kibo shares that they continue to hold at the time that they elect to exercise the Incentive
Warrants. For example, if a warrant holder exercises 100 warrants resulting in 100 new
Kibo shares being issued, they will receive 100 Incentive Warrants. If a warrant holder
holds 50 warrants at the time the warrant holder exercises their Incentive Warrant, only
50 warrants will be exercisable and the balance will lapse.
A total of up to 1,200,774,625 Incentive Warrants may be issued by the Company.
B. Conversion of 7% Convertible Loan Note Redeemable Instrument
The Company has reached agreement with the holders (the ‘Noteholders’) of the Company’s 7%
Convertible Loan Note Instrument dated 7 January 2022 (the ‘Loan Notes’), to convert all principal
amounts and accrued interest to ordinary Kibo shares of €0.001 par value. The total amount
outstanding, including accrued interest on the Loan Notes, will be £714,517 at the time of conversion
and this amount will be converted at a price of 0.14p (the ‘Conversion Price’), resulting in the issue
of 510,369,286 new Kibo shares to the Noteholders (the “Noteholder Shares”). The Conversion Price
is the same as the most recent price at which the Company issued shares (refer to Company RNS
dated 25 January 2023), as is required under the terms and conditions of the Loan Note Instrument.
It is noted that the Noteholders comprise directors, former directors and management of the Company
who had recently agreed to an extension of the redemption date of the Loan Notes to 31 May 2023
(RNS dated 1 March 2023). As outlined above, these Notes will now be redeemed by conversion to
Kibo ordinary shares.
The Noteholders will be granted warrants equal to 50% of the CLN Balance (i.e. £357,258.50)
divided by the Reference Price exercisable at €0.0015 per Ordinary Share of the Company, with a 36
month term. The warrants will only vest as exercisable once the Outstanding Balance of the below
referred Term Loan Facility (as defined below) is less than 50% as at the Execution Date.
C. Re-profiling of Institutional Investor Bridge Loan Facility
The Company has further agreed to a reprofiling of its existing bridge loan facility into a new 24-
month term loan (the ‘Term Loan Facility’). The Term Loan Facility will extend the current
repayment date (which is 28 April 2023 per the RNS dated 11 January 2023). Under the Term Loan
Facility agreement, £1,113,980 (the ‘Reprofiled Amount’) of the total amount owed under the Facility
of £1,182,254 (the ‘Outstanding Balance’), will be deemed a First Tranche Drawdown advanced to
the Company on the first trading day following the completion of the following conditions precedent:
1. Kibo’s 7% Convertible Loan Note Instruments are converted to Kibo shares in the amount
and conversion price as outlined above, resulting in the issue of 510,369,286 new Kibo shares
to Noteholders.
2. The Warrant Holders exercise up to 264,125,000 of the 1,128,024,625 Kibo warrants
outstanding at the repriced exercise price of 0.1p, resulting in cash proceeds of £264,125 to
the Company and the issue of up to 264,125,000 new Kibo shares to the Warrant Holders.
3. Following completion of (1) and (2) above, the Institutional Investor exercises 168,274,625
warrants (W.I 7 in Table 1 above), resulting in cash proceeds of £100,000 to the Company,
and £68,274 as a reduction against the amount due to be owed under the Term Loan Facility.
As part of this original bridge loan agreement, the Company provided the Institutional Investor with
security in the form of shares held by it in Mast Energy Developments Plc (“MAST”) in the amount
of 54,054,055 shares. This arrangement has been cancelled as part of the reprofiling.
The terms of repayment of the Reprofiled Amount and any additional drawdowns under the
reprofiling agreement of the Facility, comprise the following:
* The Reprofiled Amount will be subject to a six-month principal repayment holiday, followed
by 18 equal monthly cash repayments of principal and the coupon thereafter on the maturity
date unless otherwise capitalised under the terms of the reprofiled Facility, which falls 24
months from the Drawdown Date. It is noted that that the First Drawdown is the Reprofiled
Amount, and the Drawdown Date is the first trading day following satisfaction of the
condition’s precedent outlined above. Further drawdown amounts and drawdown dates will
be the subject of mutual agreement between the Investor and the Company for the duration of
the Commitment Period (defined as three (3) years from the Execution Date of the loan
reprofile agreement).
* If the Company elects not to settle a monthly payment (each being a “Missed Payment”),
they will automatically grant a right for the monthly payment to be settled in shares as per the
Non-Cash Repayment Terms, being that the Investor will be granted subscription rights over
such balances due with respect to the Missed Repayment. The Investor will have the right for
12-months to capitalise such amounts of the Missed Payment from time to time with respect
in varying amounts and without any restrictions at an 8% discount to the average of the 1 daily
VWAP chosen by the Investor in the 10 trading days preceding each relevant subscription
notice (“Adjusted Placing Price”).
* The Company will grant senior fixed and floating security over its assets, including the
shareholdings of MAST and USE as held by the Company. The Company will subordinate
the loan between the Company and MAST (refer RNS dated 15 December 2022) to the
funding of the Investor to MAST.
* The Reprofiled Amount will be subject to a 9.5% fixed coupon per 12 months of the 24-
month term for each drawdown (i.e., 19% aggregate coupon). Each coupon is calculated at
the commencement of a 12-month period based on the gross outstanding balances. The
coupon will be paid at the end of the Term unless otherwise capitalised into shares of the
Company under the terms of the Term Loan Facility but accrues on the Execution Date, with
respect to the first 12 months and on the first anniversary for the second 12 months.
* An Implementation Fee of 5% of the First Tranche (i.e., the Reprofiled Amount) is added to
the balance payable at the end of the Term, unless otherwise capitalised under the terms of
the reprofiled Facility, but accrues on the Execution Date and an additional 5% of each
relevant drawdown (to be deducted from gross proceeds).
* If the Company fails to pay any sum on the due date for payment certain default terms,
including additional fees and conversion of outstanding amounts, would then apply.
The Institutional Investor shall receive Warrants equal to 100% of each Drawdown divided by the
Reference Price. With respect to the Drawdown for the Reprofiled Amount, being £0.001 per Share
and, with respect to any further Drawdown, being the average of the 5 daily volume weight average
prices prior to the Drawdown Date. Half of the warrants will be exercisable at the relevant Reference
Price and the other half will be exercisable at 200% of the relevant Reference Price. The exercise
period will be as follows:
* 36 months if the outstanding balance is settled in full within 12 months of the date of Term
Loan Facility agreement; and
* 48-month term from the date of issuance if the outstanding balance is not settled in full within
12 months of the date of Term Loan Facility agreement.
The exercise of the warrants may be offset against outstanding debt pursuant to the Term Loan
Facility.
Implementation of the measures outlined in A to C above is expected to result in the newly issued
share capital being 3,995,991,683*. The number of shares and warrants held by the directors of the
Company and their related parties before and after the conversion of the Loan Notes is shown in
Table 2 below.
*assuming 264,125,000 shares issued pursuant to exercises of Warrants excluding the Institutional Investor and
168,274,625 shares issued pursuant to exercises of Warrants by the Institutional Investor.
Before Loan Notes Conversion After Loan Notes Conversion
Number of
Shares held
shares
Shares held as as % of
acquired as
Number % of current Number issued share
Number of result of Number of
of Kibo issued share of Kibo capital after
Director Name Kibo shares conversion of Kibo
warrants capital warrants all measures
held 7% shares held
held (3,053,222,772 held implemented
Convertible
shares) (3,995,991,68
Loan Note
3 shares)
Instruments
Louis Coetzee &
19,505,996 None 0.64% 199,875,715 219,381,711 None 5.49%
Related Parties
Noel O’Keeffe
& Related 7,037,047 None 0.23% 50,197,857 57,234,904 None 1.43%
Parties
Chris Schutte &
None None n/a None n/a None n/a
Related Parties
Ajay Saldanha
& Related None None n/a None n/a None n/a
Parties
Total 26,543,043 n/a n/a 250,073,572 276,616,615 n/a 6.92%
Table 2: Kibo Director & Related Parties’ Kibo holdings before and after Loan Note Conversion
Louis Coetzee, CEO of Kibo Energy PLC, says: “We are pleased to have reached agreement with
various stakeholders to implement several measures to ensure the Company’s financial and
operational stability and to secure its development plans. The warrant repricing aims to provide more
favorable terms to warrant holders, most of which include existing shareholders, while supporting
the Company’s funding requirement.
“Additionally, the conversion of the convertible loan notes will deleverage the Company’s balance
sheet by significantly reducing its debt exposure. The commitment by noteholders is also testament
of their confidence in the Company’s strategy and long-term development plans to deliver renewable
energy projects that are commercially viable.”
**ENDS**
This announcement contains inside information as stipulated under the Market Abuse Regulations
(EU) no. 596/2014 and is announced in accordance with the Company’s obligations under Article
17 of the specified Regulation.
For further information please visit www.kibo.energy or contact:
Louis Coetzee info@kibo.energy Kibo Energy PLC Chief Executive Officer
James Biddle
Roland Cornish +44 207 628 3396 Beaumont Cornish Limited Nominated Adviser
Claire Noyce +44 20 3764 2341 Hybridan LLP Joint Broker
Damon Heath +44 207 186 9952 Shard Capital Partners LLP Joint Broker
Zainab Slemang Investor and Media
zainab@lifacommunications.com Lifa Communications
van Rijmenant Relations Consultant
Johannesburg
11 April 2023
Corporate and Designated Adviser
River Group
Date: 11-04-2023 08:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.